BMS Latest to Quit Consumer Health with UPSA Divestment

By Jawala Prasad & Michelle Liu

Pharma Deals Review: Vol 2019 Issue 1 (Table of Contents)

Published: 10 Jan-2019

DOI: 10.3833/pdr.v2019.i1.2393     ISSN: 1756-7874

Section: Mergers & Acquisitions



In a bid to streamline its focus towards its core business, Bristol-Myers Squibb has decided to divest its consumer health business, Union Pharmacologique Scientifique Appliquee (UPSA), following a strategic review announced in June 2018...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details